Acute Haemodynamic Effects of Peritoneal Dialysis as Evaluated by Sphygmocor Technology

This study has been completed.
Sponsor:
Information provided by:
University Hospital, Ghent
ClinicalTrials.gov Identifier:
NCT00407134
First received: November 30, 2006
Last updated: December 19, 2007
Last verified: December 2007
  Purpose

Subjects with peritoneal dialysis are randomized to different groups. The different groups receive different intra-abdominal volumes and different glucose-concentrations.

The effects on blood pressure and other cardiovascular parameters (e.g. central blood pressure, augmentation index, ...) will be evaluated.


Condition Intervention
Peritoneal Dialysis
Procedure: Different abdominal volumes and different glucose-concentrations during peritoneal dialysis

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Acute Haemodynamic Effects of Peritoneal Dialysis as Evaluated by Sphygmocor Technology

Resource links provided by NLM:


Further study details as provided by University Hospital, Ghent:

Primary Outcome Measures:
  • Blood pressure

Estimated Enrollment: 20
Study Start Date: December 2006
Study Completion Date: April 2007
  Eligibility

Ages Eligible for Study:   18 Years to 80 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Subjects with peritoneal dialysis
  • Aged 18-80 years
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00407134

Locations
Belgium
University Hospital Ghent
Ghent, Belgium, 9000
Sponsors and Collaborators
University Hospital, Ghent
Investigators
Principal Investigator: Wim Van Biesen, MD, PhD University Hospital, Ghent
  More Information

Additional Information:
No publications provided

ClinicalTrials.gov Identifier: NCT00407134     History of Changes
Other Study ID Numbers: 2006/382
Study First Received: November 30, 2006
Last Updated: December 19, 2007
Health Authority: Belgium: Institutional Review Board

ClinicalTrials.gov processed this record on August 28, 2014